PHI with Other adrenal cortex hyperfunction
How does this condition affect your private health insurance?
Nebennierenrinden-Überfunktion (Adrenal Cortex Hyperfunction, unspecified) refers to excessive production of hormones by the adrenal cortex, often involving cortisol (Cushing's syndrome), aldosterone (primary aldosteronism), or adrenal androgens. Symptoms vary depending on the specific hormone excess but commonly include hypertension, metabolic disturbances (like hyperglycemia), weight gain, muscle weakness, skin changes, and immune suppression. The condition can result from adrenal tumors (benign or malignant), adrenal hyperplasia, or in some cases, pituitary tumors stimulating adrenal activity. If left untreated, it can lead to severe cardiovascular complications, infections, and metabolic crises, significantly impacting quality of life and lifespan.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months, as symptoms typically develop gradually.
Duration of Illness (Lifetime)
Chronic if untreated; potentially curable depending on the underlying cause (e.g., resectable tumor).
Cost of Treatment (Initial)
High (e.g., several thousand to tens of thousands USD) for diagnosis, imaging, hormone tests, and initial management.
Cost of Treatment (Lifetime)
Significant and ongoing if chronic, potentially very high if surgical intervention and long-term follow-up are required.
Mortality Rate
Moderate to high if untreated due to cardiovascular complications, infections, and metabolic imbalances; significantly reduced with proper diagnosis and management.
Risk of Secondary Damages
Very high; common secondary damages include severe hypertension, diabetes mellitus, osteoporosis, muscle atrophy, increased infection risk, and psychological disturbances.
Probability of Full Recovery
Variable; high if the underlying cause (e.g., a benign adrenal adenoma or pituitary adenoma) can be completely removed; lower for diffuse hyperplasia requiring lifelong medical management.
Underlying Disease Risk
High; commonly associated with hypertension, diabetes mellitus, osteoporosis, and in specific cases, pituitary adenomas (Cushing's disease) or specific adrenal tumors.